Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1393769 | Chemistry & Biology | 2011 | 10 Pages |
Summaryc-Abl kinase activity is regulated by a unique mechanism involving the formation of an autoinhibited conformation in which the N-terminal myristoyl group binds intramolecularly to the myristoyl binding site on the kinase domain and induces the bending of the αI helix that creates a docking surface for the SH2 domain. Here, we report a small-molecule c-Abl activator, DPH, that displays potent enzymatic and cellular activity in stimulating c-Abl activation. Structural analyses indicate that DPH binds to the myristoyl binding site and prevents the formation of the bent conformation of the αI helix through steric hindrance, a mode of action distinct from the previously identified allosteric c-Abl inhibitor, GNF-2, that also binds to the myristoyl binding site. DPH represents the first cell-permeable, small-molecule tool compound for c-Abl activation.
► Identified a potent, small-molecule c-Abl kinase activator, DPH ► Structural studies revealed a distinct mechanism for DPH ► DPH demonstrated potent cellular activity in stimulating c-Abl activation ► DPH is the first cell-permeable, small-molecule tool for c-Abl activation